Jefferies: CHINAHONGQIAO (01378) benefits from the rise in aluminum prices, target price raised to 43.8 Hong Kong dollars.
Jefferies released a report stating that China Hongqiao (01378) will become the main beneficiary of the rebound in aluminum prices. The bank reiterated its "buy" rating and raised its target price from HK$34.1 to HK$43.8.
Jefferies released a report stating that CHINAHONGQIAO (01378) will be one of the main beneficiaries of the rebound in aluminum prices. The firm reiterated its "buy" rating and raised its target price from HK$34.1 to HK$43.8.
Jefferies stated that the stock prices of the copper and aluminum sectors have not fully reflected the current strength of commodity prices, while the valuation of the lithium sector seems more reasonable. Considering the limited supply and demand driven by energy transformation, AI themes, and recent macroeconomic and geopolitical factors, the firm remains optimistic about the long-term prospects and is bullish on copper and aluminum.
The firm pointed out that CHINAHONGQIAO, as one of the world's leading aluminum producers, has a core advantage in its extremely strong cost competitiveness, ranking in the top tier of China's aluminum production cost curve.
This "moat" is mainly built on two dimensions: 1) complete self-sufficiency in key raw materials: the company has achieved full self-sufficiency in bauxite and alumina, greatly hedging against the risk of rising upstream raw material prices, ensuring stability in profit margins; 2) efficient production, the company has achieved lower unit energy consumption through technological optimization.
In addition, the company provides significant shareholder returns through dividends (with a payout ratio of over 60%) and buybacks.
Related Articles

Over the past year, GAUSH MEDITECH (02407) has been stuck in a liquidity quagmire, urgently needing a strong financial report to "save the day"?

Ming Ming is very busy today as it is listed on the Hong Kong Stock Exchange with the aim to provide "quality-price ratio" services for millions of families.

New Stock News | RECBIO-B(02179) Domestic Unlisted Shares "Fully Circulated" Approved by China Securities Regulatory Commission
Over the past year, GAUSH MEDITECH (02407) has been stuck in a liquidity quagmire, urgently needing a strong financial report to "save the day"?

Ming Ming is very busy today as it is listed on the Hong Kong Stock Exchange with the aim to provide "quality-price ratio" services for millions of families.

New Stock News | RECBIO-B(02179) Domestic Unlisted Shares "Fully Circulated" Approved by China Securities Regulatory Commission

RECOMMEND

New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026

117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026

“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026


